Headquarters
211 E 70TH ST 3H, NEW YORK, NY 10021-5206, US
NEW YORK, NY, US
DEFINITIVE DIAGNOSTICS, INC
From the company
Definitive Diagnostics develops an AI-enabled, protein-based blood test platform for earlier cancer detection. Its patented method measures 16 abundant protein/immune biomarkers forming cancer-specific patterns, designed to reduce false positives and unnecessary procedures. The company reports independent validation of 99% sensitivity (Stage 0 breast), 97% specificity, and 98% Tissue of Origin, and has detected cancer as early as Stage 0 in breast and Stage I in lung, colorectal, ovarian, and pancreatic cancers.
Products & services offered
Capabilities 5
Classifications
- Ownership classifications (1)
- Self Certified Small Disadvantaged Business
Facilities
Send your requirements
Quantities, certifications, and timing.